LeadIQ logo
Learn more at LeadIQ.com

Insights

Funding Highlights A-Alpha Bio has recently secured significant funding, including a $14.5 million financing from the Department of Defense to prepare for future biological threats. This influx of capital not only signifies the company's growth but also presents opportunities for partnership and collaboration with government agencies or defense contractors.

Strategic Partnerships The partnership between A-Alpha Bio and Amgen Foundation to identify and validate ligase-target pairs for molecular glue discovery showcases the company's collaborative approach towards innovation. Leveraging such strategic partnerships can open doors for joint research projects, co-development opportunities, and access to Amgen's network and resources.

Series A Funding Expansion With a recent $51 million Series A extension funding led by Perceptive Xontogeny Venture Fund, A-Alpha Bio has demonstrated investor confidence in its technology and growth potential. This additional funding could signify scalability and product development milestones, making the company an attractive target for potential investors or acquisition partners.

Expert Board Addition The appointment of Heidi Hagen to the Board of Directors adds valuable expertise to A-Alpha Bio's leadership team. Heidi's background in synthetic biology and her industry connections could present opportunities for strategic guidance, networking with industry experts, and potential business development avenues through her affiliations.

Market Positioning A-Alpha Bio's focus on harnessing synthetic biology and machine learning to engineer protein-protein interactions positions the company at the forefront of biotechnology research. This innovative approach not only differentiates A-Alpha Bio from competitors but also presents opportunities to showcase unique capabilities to potential clients and collaborators seeking cutting-edge solutions.

Similar companies to A-Alpha Bio

A-Alpha Bio Tech Stack

A-Alpha Bio uses 8 technology products and services including SciPy, Fastly, PWA, and more. Explore A-Alpha Bio's tech stack below.

  • SciPy
    Advanced Analytics And Data Science
  • Fastly
    Content Delivery Network
  • PWA
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • JavaScript
    Programming Languages
  • Bootstrap
    UI Frameworks

Media & News

A-Alpha Bio's Email Address Formats

A-Alpha Bio uses at least 1 format(s):
A-Alpha Bio Email FormatsExamplePercentage
FLast@aalphabio.comJDoe@aalphabio.com
49%
FMiddleLast@aalphabio.comJMichaelDoe@aalphabio.com
1%
FLast@aalphabio.comJDoe@aalphabio.com
49%
FMiddleLast@aalphabio.comJMichaelDoe@aalphabio.com
1%

Frequently Asked Questions

Where is A-Alpha Bio's headquarters located?

Minus sign iconPlus sign icon
A-Alpha Bio's main headquarters is located at 2101 4th Ave Fifth Floor Seattle, Washington 98121 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is A-Alpha Bio's official website and social media links?

Minus sign iconPlus sign icon
A-Alpha Bio's official website is aalphabio.com and has social profiles on LinkedIn.

How much revenue does A-Alpha Bio generate?

Minus sign iconPlus sign icon
As of September 2024, A-Alpha Bio's annual revenue reached $15M.

What is A-Alpha Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
A-Alpha Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does A-Alpha Bio have currently?

Minus sign iconPlus sign icon
As of September 2024, A-Alpha Bio has approximately 57 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Business Officer: P. K.Vice President Of Technical Operations & Engineering: L. S.Co-founder & CTO: R. L.. Explore A-Alpha Bio's employee directory with LeadIQ.

What industry does A-Alpha Bio belong to?

Minus sign iconPlus sign icon
A-Alpha Bio operates in the Biotechnology Research industry.

What technology does A-Alpha Bio use?

Minus sign iconPlus sign icon
A-Alpha Bio's tech stack includes SciPyFastlyPWAOpen GraphMicrosoftAmazon Web ServicesJavaScriptBootstrap.

What is A-Alpha Bio's email format?

Minus sign iconPlus sign icon
A-Alpha Bio's email format typically follows the pattern of . Find more A-Alpha Bio email formats with LeadIQ.

How much funding has A-Alpha Bio raised to date?

Minus sign iconPlus sign icon
As of September 2024, A-Alpha Bio has raised $15M in funding. The last funding round occurred on May 21, 2024 for $15M.

When was A-Alpha Bio founded?

Minus sign iconPlus sign icon
A-Alpha Bio was founded in 2017.
A-Alpha Bio

A-Alpha Bio

Biotechnology ResearchWashington, United States51-200 Employees

A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of Washington's Institute for Protein Design and Center for Synthetic Biology. To learn more, please visit: https://www.aalphabio.com/

Section iconCompany Overview

Headquarters
2101 4th Ave Fifth Floor Seattle, Washington 98121 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $15M

    A-Alpha Bio has raised a total of $15M of funding over 9 rounds. Their latest funding round was raised on May 21, 2024 in the amount of $15M.

  • $10M$50M

    A-Alpha Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $15M

    A-Alpha Bio has raised a total of $15M of funding over 9 rounds. Their latest funding round was raised on May 21, 2024 in the amount of $15M.

  • $10M$50M

    A-Alpha Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.